health

A Southern California disc jockey underwent a unique surgery to fix an aortic aneurysm without causing any harm to his vocal cords.

Study finds that AT2101, a drug developed to treat Gaucher disease, helped halt the progression of Parkinson’s in mice.

Developed by UCLA’s Dr. Leonard Rome and Dr. Steven Dubinett, the treatment combines an immunotherapy agent with a drug delivery nanotechnology using nanoparticles called vaults.

After being sidelined because of poor circulation, the 16-year-old can practice and compete again thanks to an unusual aortic surgery.

A researcher at UCLA’s Jonsson Comprehensive Cancer Center helped develop the combination drug therapy that also lowers the risk of secondary cancers.

In a small-scale study, nine of 10 people with the disease displayed subjective or objective improvement in their memories beginning within three to six months.

A University of California center that fosters health care innovation at UC's five medical centers is proving to be a boon to both patient health and the bottom line.

Combining resveratrol with benzoyl peroxide created a “two-pronged attack” on the bacteria that cause acne.

Souped-up antibiotics effectively attack persister cells that are responsible for making bacteria resistant to new drugs.

Motivated by a drive ‘to do work that can save lives,’ UCLA's Mark Kaplan has become a leading expert on suicide, the 10th-leading cause of death in the United States.

Research by UCLA biochemists may lead to a new treatment — or even a cure — for a rare kidney disease that afflicts children, and may provide insights into treatments for Parkinson’s, Alzheimer’s and other degenerative diseases.

‘Souped-up’ antibiotics could give doctors an advantage over bacteria that have develop immunity to medicines.

Myra and David Mezquita have been struggling to pay for nursing care for their daughter Vicky, who is being treated for the second time for recurring living cancer. An organization founded by Westside teenagers has come to their aid.

The authors say medical school and four-year university recruitment, outreach and admissions practices should be more inclusive of community college students.

Mary Jane Rotheram-Borus says that the near-ubiquity of alcohol contributes to the staggering toll fetal alcohol spectrum disorders take on society each year.

About 50 UCLA health care workers ranging from nurses to cardiologists and ophthalmologists, volunteered at this year's free health clinic for the poor and underserved sponsored by Care Harbor.

Study finds that that men who aren’t well educated about their disease have a much more difficult time making treatment decisions. This "decisional conflict" could negatively impact their long-term outcomes.

UCLA specialists have assembled kits containing protective gear to be used in the event that a patient infected with Ebola or other infectious diseases arrives at the emergency room for treatment.

Anthem Blue Cross Vivity will provide members with more predictable costs, a simpler experience and convenient access to some of the best primary care doctors, specialists and hospitals in the region.

Doctors from UCLA Health System are now available on smartphones, tablets and laptops through LiveHealth Online, a telehealth solution ideal for business travelers, busy parents, students away at college or others who need non-emergency attention.

UCLA study finds that a common form of psychotherapy is most effective at alleviating sleeplessness.

Headed for a career in medicine, Megan Cory turned her own diagnosis of type 1 diabetes into an opportunity to do research, raise funds and help inform the public about ways to prevent diabetes.

“In short, if you think a pill is going to work, it probably will,” says UCLA professor who led the study, which evaluated patients who received therapy and either real medication or a sugar pill.

High doses appear not to offer the same benefit, but the lower dosage may be a safe, low-cost way to help people with epilepsy, UCLA study suggests.

Approval of Keytruda signals a paradigm shift in the way advanced melanoma is treated. The drug was tested on more than 600 patients in the U.S., Europe and Australia.